Molecular Partners AG
MOLN
$5.53
Closing
▼-7.37%
1D
▲38.94%
YTD
MOLN
BBG010B7DJV0
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$227.13M
Analysts' Rating
HOLD
Price Target (Mean)
11.50
Total Analysts
1
P/E
Operating Margin
-1030.05%
Beta
1.01
Revenue Growth
273.73%
52 week high
$12.70
52 week low
$3.35
Div. Yield
%
EPS Growth
0.00
Company Profile
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
